Metabolism and metabolic inhibition of cilnidipine in human liver microsomes

Acta Pharmacologica Sinica

Volumn 24, Issue 3, 2003, Pages 263-268

  Liu, Xiao Quan ^a   Zhao, Yang ^a   Li, Dan ^a   Qian, Zhi Yu ^a   Wang, Guang Ji ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cilnidipine; Cytochrome P 450; Liver microsomes; Metabolism

Indexed keywords

CILNIDIPINE; CYTOCHROME P450; KETOCONAZOLE; SULFAPHENAZOLE; TRANYLCYPROMINE;

ARTICLE; COMPETITIVE INHIBITION; DEMETHYLATION; DRUG EFFECT; DRUG ELIMINATION; DRUG METABOLISM; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; LIVER METABOLISM; LIVER MICROSOME; METABOLIC INHIBITION; METABOLIC RATE; MOLECULAR INTERACTION;

ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; DIHYDROPYRIDINES; HUMANS; KETOCONAZOLE; MICROSOMES, LIVER; OXIDOREDUCTASES, N-DEMETHYLATING;

EID: 0037336297     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Yoshimoto R, Dohmoto H, Yamada K, Goto A. Prolonged inhibition of vascular contraction and calcium influx by the novel 1, 4-dihydropyridine calcium antagonist cilnaldipine (FRC-8653). Jpn J Pharmacol 1991; 56: 225-9.
2. 2+ channel blocker, on stroke and hypertensive complications in stroke-prone spontaneously hypertensive rats (SHRSP) [abstract]. Jpn J Pharmacol 1993; 61 (Suppl 1): 118.
3. Mealy N, Castaner J. Cilnidipine. Drugs Future 1996; 21: 249-53.
4. Vonbahr C, Groth CG, Jansson H, Lundgren G, Lind M, Glaumann H. Drug metabolism in human liver in vitro: establishment of a human liver bank. Clin Pharmacol Ther 1980; 27: 711-25.
5. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 256-75.
6. Kimonen T, Juvonen RO, Alhava E, Pasanen M. The inhibition of CYP enzymes in mouse and human liver by pilocarpine. Br J Pharmacol 1995; 114: 832-6.
7. Liu XQ, Ren YL, Qian ZY, Wang GJ. Enzyme kinetics and inhibition of nimodipine metabolism in human liver microsomes. Acta Pharmacol Sin 2000; 21: 690-4.
8. Newton DJ, Wang RW, Lu AYH. Cytochrome P450 inhibitors. Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metab Dispos 1995; 23: 154-8.
9. Liu XQ, Ren YL, Peng JH, Qian ZY, Wang GJ. Metabolism of nimodipine in human liver microsomes. Chin Pharmacol Toxicol 2000; 14: 449-52.
10. Zhao Y, Liu XQ, Qian ZY, Fan XL, Ren YL. Enzyme kinetics and inhibition of felodipine metabolism in human liver microsomes. J China Pharm Univ 2001; 32: 112-6.
11. Nakajima M, Inoue T, Shimada N, Tokudome S, Yamamoto T, Kuroiwa Y. Cytochrome P450 2C9 catalyzes indomethacin O-demethylation in human liver microsomes. Drug Metab Dispos 1998; 26: 261-6.